Trump Administration Executive Order (EO) Tracker
Preference center
Error: Please select at least one topic, language, and country.
Preference center
Update my profile
You can edit your details here.
* If you need to update your email address, contact our support team.
Manage my preferences
Choose how often you’d like to receive alerts and personalize your interests by selecting your language, topics and countries then save changes.
-
Alerts
-
Regular alert frequency
Update your preferences, indicate what content is of interest to you, and determine the frequency of the emails you’ll receive. Our emails are sent daily, on a Tuesday (weekly or every two weeks), or monthly.
- Never
- Daily
- Weekly
- Fortnightly
- Monthly
-
Instant alerts
Set your preferences for instant alerts on critical or time sensitive developments. Updates on some topics are available as instant alerts only.
- All instant alerts
-
Opt out of all Hogan Lovells emails
By selecting unsubscribe, you will opt out of receiving all Hogan Lovells emails.
- Unsubscribe
We have regular alerts where you can set your preferences and frequency and we also have instant alerts on critical or time sensitive developments.
You can change your preferences any time. Any changes you make here will take effect within 2-3 business days. -
-
Topics
- Select all topics
-
Customise topics by industry
-
Aerospace and Defense
-
Automotive and Mobility
-
Consumer
- E-Commerce
- Electronics and Consumer Appliances
- Retail and Fashion
-
Education
-
Energy and Natural Resources
- Energy Transition
- Hydrogen
- Mining
- Nuclear
- Oil, Gas and LNG
- Power, renewables and alternative energy
-
Insurance / re-insurance
-
Life Sciences and Health Care
- Cell, Tissue, and Gene Therapies (CTGT)
- Clinical Trials
- Combination Products
- Digital Health
- Emerging Companies and Investors
- Hospitals and Health Care Providers
- Licensing and Commercial Transactions
- Life Science Government Enforcement and Compliance
-
Manufacturing and Industrials
- Chemicals and Industrial Products and Services
- Conglomerates
-
Media and Entertainment
-
Private Capital
- Fund Formation, Fund Raising, Restructuring and Dissolution
- Infrastructure and Energy Funds
- Investments, Financing, Portfolio Company Advice and Exits
- Pension Funds
- Private Capital Regulatory, Compliance and Disputes
- Private Credit-Debt Funds
- Private Equity Funds
- Real Estate Investment Vehicles and Funds
- Sovereign Wealth Funds
- Venture Capital Funds
-
Real Estate
- Cross-border Real Estate
- Development, Planning and Land Use
- ESG in Real Estate
- Hotels and Leisure
- Real Estate Investment Vehicles and Funds
- Real Estate Disputes
- Real Estate Finance
-
Sports
-
Technology
-
Telecommunications and Internet
-
Aerospace and Defense
-
Customise topics by issue
-
Global Market Issues
- Artificial Intelligence
- Brexit
- COVID-19
- Digital Transformation
- Digital Services Act and Digital Markets Act
- ESG, Sustainability, and Climate
- EU Green Deal
- Federal Trade Commission (FTC)
- Foreign Direct Investment
- Inflation Reduction Act
- Russia sanctions
- Supply Chain
- UK2030
-
Administrative and Public Law
- Commercial Human Rights
- Constitutional Law
- Freedom of Information
- Judicial Review
- Public Law
-
Antitrust and Competition
- Competition Litigation and Disputes
-
Banking and Loan Finance
- Leveraged and Acquisition Finance
-
Business and Human Rights
-
Capital Markets
- Derivatives and Structured Products
- Equity Capital Markets
- General Debt Capital Markets
- High Yield
- Securitization and Structured Finance
- Trust and Agency
-
Corporate Governance / Public Company Advisory / Company Law
-
Construction and Engineering
-
Data, Privacy and Cybersecurity
-
Employment
-
Environment
- Environmental Compliance, Litigation and Internal Investigations
-
Esports and Gaming
-
Executive Compensation, Employee Benefits and Share Incentives
-
Financial Services
- Banking Products
- Consumer Finance
- Digital Assets and Blockchain
- Financial Crime including Anti-money Laundering
- Financial Services Litigation and Disputes
- Financial Services Privacy
- Financial Services Regulatory Investigations and Enforcement
- Financial Services Securities and Markets Regulation
- FinTech
- Funds and Asset Management
- Open Banking
- Payments
- Prudential Regulation
-
Food and Beverage
-
Gaming and Gambling Law
- Gaming and Gambling Related Payments Services
- Online Gaming and Gambling
-
Government Contracts and Public Procurement
-
Government Relations
- Congressional Oversight and Investigation
- Devolution and devolved administrations
- Federal Funding and Appropriations
- Legislation and Policy Engagement and Development
- Political Law Compliance
- Public Policy and Regulation
- Sovereign Government Relations and Public Affairs
- State,Local Government Representation and Policy
- UK Parliamentary Affairs
-
Health Regulatory
- Coverage and Reimbursement
- Drug Pricing and Government Reporting
- Health Compliance, Fraud and Abuse
- Health Insurance Plans and Managed Care
- Health Policy and Advocacy
- Health Privacy
-
Infrastructure, Energy, Resources and Projects
-
Intellectual Property
- Copyright
- Designs
- Domain Names
- IP and Technology Transactions
- Patents
- Trademarks and Brands
- Trade Secrets and Confidential Know-how
- Unfair Competition
-
International Arbitration
-
International Trade and Investment
-
Investigations, White Collar and Fraud
- Bribery and Corruption
- False Claims Act
- Financial Crime
- Investigations, Regulatory and Compliance
- Whistleblowing
-
Medical Device and Technology Regulatory
- Advertising and Promotion of Medical Devices
- Clinical Studies Product Design and Development
- Conformity Assessment Procedure,CE Mark
- In Vitro Diagnostics
- Joint Ventures and Strategic Alliances
- MDR,IVDR
- Medical Device Software and Cybersecurity
- Postmarket Performance
- Premarket Strategy, Submissions, and Review
- Regulatory Inspections and QSR-ISO 13485
- State Licensing of Medical Device
-
Mergers and Acquisitions
- Joint Ventures and Strategic Alliances
-
Pensions
-
Pharmaceuticals and Biotechnology Regulatory
- Advertising and Promotion of Pharmaceuticals and Biotechnology
- Biologics and Biosimilars
- Controlled Substances
- Life Cycle Management of Pharmaceuticals and Biotechnology
- OTC Drugs and Cosmetics
- Regulatory Exclusivities, Hatch-Waxman, and Similar Statutes
- Regulatory Inspections and cGMP
-
Private Equity, Venture Capital and Investment Funds
- Fund Formation, Fund Raising, Restructuring and Dissolution
- Management Incentive Programs
- Private Equity Transactions
- Secondaries
- Venture Capital Transactions
-
Products Law
-
REITs
-
Restructuring and Special Situations
-
Risks, Disputes, and Litigation
- Business Restructuring and Insolvency Litigation
- Class Actions and Group Actions
- Competition Litigation and Disputes
- Corporate and Securities Litigation
- Crisis Management
- Financial Services Litigation and Disputes
- Global Asset Recovery and Enforcement
- Real Estate Disputes
- Sovereign Asset Recovery
- Technology Litigation and Disputes
- U.S. Appellate and Supreme Court Litigation
-
Space and Satellite
-
Strategic Operations, Agreements and Regulation
- Commercial Law and Contracts
-
Sustainable Finance
-
Tax
-
Transfer Pricing
-
Transportation and Logistics
- Logistics
- Mobility
- Rail
- Shipping
- Uncrewed Aircraft Systems-Advanced Air Mobility-Drone Security
-
Global Market Issues
-
Languages
- Select all languages
- 中文
- Deutsch
- English
- Español
- Français
- 日本語
- Português
We have regular alerts where you can set your preferences and frequency and we also have instant alerts on critical or time sensitive developments.
-
Countries
- Select all countries
-
Africa
- Central Africa
- Eastern Africa
- Northern Africa
- South Africa
- Southern Africa
- Western Africa
-
Asia Pacific
- Australia
- People's Republic of China
- Hong Kong
- Indonesia
- Japan
- Singapore
- South Korea
- Vietnam
-
Europe
- Belgium
- France
- Germany
- Hungary
- Ireland
- Italy
- Luxembourg
- Netherlands
- Poland
- Spain
- United Kingdom
-
Latin America
- Brazil
- Mexico
-
Middle East
- Saudi Arabia
- United Arab Emirates
-
North America
- United States
Update my profile
* If you need to update your email address, contact our support team.
Manage my preferences
Alerts
Choose how often you’d like to receive alerts and personalize your interests by selecting your language, topics and countries then save changes.
Regular alert frequency
Update your preferences, indicate what content is of
interest
to you, and determine the frequency of the emails you’ll receive. Our emails are sent daily, on a Tuesday (weekly or every two weeks), or monthly.
- Never
- Daily
- Weekly
- Fortnightly
- Monthly
Instant alerts
Set your preferences for instant
alerts on critical or time sensitive developments. Updates on some
topics are available as instant alerts only.
- All instant alerts
Opt out of all Hogan Lovells emails
By selecting unsubscribe, you will opt out of
receiving all Hogan Lovells emails.
- Unsubscribe
You can change your preferences any time. Any changes you make here will take effect within 2-3 business days.
Manage my preferences
Topics
Customise topics by industry
-
Aerospace and Defense
-
Automotive and Mobility
-
Consumer
- E-Commerce
- Electronics and Consumer Appliances
- Retail and Fashion
-
Education
-
Energy and Natural Resources
- Energy Transition
- Hydrogen
- Mining
- Nuclear
- Oil, Gas and LNG
- Power, renewables and alternative energy
-
Insurance / re-insurance
-
Life Sciences and Health Care
- Cell, Tissue, and Gene Therapies (CTGT)
- Clinical Trials
- Combination Products
- Digital Health
- Emerging Companies and Investors
- Hospitals and Health Care Providers
- Licensing and Commercial Transactions
- Life Science Government Enforcement and Compliance
-
Manufacturing and Industrials
- Chemicals and Industrial Products and Services
- Conglomerates
-
Media and Entertainment
-
Private Capital
- Fund Formation, Fund Raising, Restructuring and Dissolution
- Infrastructure and Energy Funds
- Investments, Financing, Portfolio Company Advice and Exits
- Pension Funds
- Private Capital Regulatory, Compliance and Disputes
- Private Credit-Debt Funds
- Private Equity Funds
- Real Estate Investment Vehicles and Funds
- Sovereign Wealth Funds
- Venture Capital Funds
-
Real Estate
- Cross-border Real Estate
- Development, Planning and Land Use
- ESG in Real Estate
- Hotels and Leisure
- Real Estate Investment Vehicles and Funds
- Real Estate Disputes
- Real Estate Finance
-
Sports
-
Technology
-
Telecommunications and Internet
Customise topics by issue
-
Global Market Issues
- Artificial Intelligence
- Brexit
- COVID-19
- Digital Transformation
- Digital Services Act and Digital Markets Act
- ESG, Sustainability, and Climate
- EU Green Deal
- Federal Trade Commission (FTC)
- Foreign Direct Investment
- Inflation Reduction Act
- Russia sanctions
- Supply Chain
- UK2030
-
Administrative and Public Law
- Commercial Human Rights
- Constitutional Law
- Freedom of Information
- Judicial Review
- Public Law
-
Antitrust and Competition
- Competition Litigation and Disputes
-
Banking and Loan Finance
- Leveraged and Acquisition Finance
-
Business and Human Rights
-
Capital Markets
- Derivatives and Structured Products
- Equity Capital Markets
- General Debt Capital Markets
- High Yield
- Securitization and Structured Finance
- Trust and Agency
-
Corporate Governance / Public Company Advisory / Company Law
-
Construction and Engineering
-
Data, Privacy and Cybersecurity
-
Employment
-
Environment
- Environmental Compliance, Litigation and Internal Investigations
-
Esports and Gaming
-
Executive Compensation, Employee Benefits and Share Incentives
-
Financial Services
- Banking Products
- Consumer Finance
- Digital Assets and Blockchain
- Financial Crime including Anti-money Laundering
- Financial Services Litigation and Disputes
- Financial Services Privacy
- Financial Services Regulatory Investigations and Enforcement
- Financial Services Securities and Markets Regulation
- FinTech
- Funds and Asset Management
- Open Banking
- Payments
- Prudential Regulation
-
Food and Beverage
-
Gaming and Gambling Law
- Gaming and Gambling Related Payments Services
- Online Gaming and Gambling
-
Government Contracts and Public Procurement
-
Government Relations
- Congressional Oversight and Investigation
- Devolution and devolved administrations
- Federal Funding and Appropriations
- Legislation and Policy Engagement and Development
- Political Law Compliance
- Public Policy and Regulation
- Sovereign Government Relations and Public Affairs
- State,Local Government Representation and Policy
- UK Parliamentary Affairs
-
Health Regulatory
- Coverage and Reimbursement
- Drug Pricing and Government Reporting
- Health Compliance, Fraud and Abuse
- Health Insurance Plans and Managed Care
- Health Policy and Advocacy
- Health Privacy
-
Infrastructure, Energy, Resources and Projects
-
Intellectual Property
- Copyright
- Designs
- Domain Names
- IP and Technology Transactions
- Patents
- Trademarks and Brands
- Trade Secrets and Confidential Know-how
- Unfair Competition
-
International Arbitration
-
International Trade and Investment
-
Investigations, White Collar and Fraud
- Bribery and Corruption
- False Claims Act
- Financial Crime
- Investigations, Regulatory and Compliance
- Whistleblowing
-
Medical Device and Technology Regulatory
- Advertising and Promotion of Medical Devices
- Clinical Studies Product Design and Development
- Conformity Assessment Procedure,CE Mark
- In Vitro Diagnostics
- Joint Ventures and Strategic Alliances
- MDR,IVDR
- Medical Device Software and Cybersecurity
- Postmarket Performance
- Premarket Strategy, Submissions, and Review
- Regulatory Inspections and QSR-ISO 13485
- State Licensing of Medical Device
-
Mergers and Acquisitions
- Joint Ventures and Strategic Alliances
-
Pensions
-
Pharmaceuticals and Biotechnology Regulatory
- Advertising and Promotion of Pharmaceuticals and Biotechnology
- Biologics and Biosimilars
- Controlled Substances
- Life Cycle Management of Pharmaceuticals and Biotechnology
- OTC Drugs and Cosmetics
- Regulatory Exclusivities, Hatch-Waxman, and Similar Statutes
- Regulatory Inspections and cGMP
-
Private Equity, Venture Capital and Investment Funds
- Fund Formation, Fund Raising, Restructuring and Dissolution
- Management Incentive Programs
- Private Equity Transactions
- Secondaries
- Venture Capital Transactions
-
Products Law
-
REITs
-
Restructuring and Special Situations
-
Risks, Disputes, and Litigation
- Business Restructuring and Insolvency Litigation
- Class Actions and Group Actions
- Competition Litigation and Disputes
- Corporate and Securities Litigation
- Crisis Management
- Financial Services Litigation and Disputes
- Global Asset Recovery and Enforcement
- Real Estate Disputes
- Sovereign Asset Recovery
- Technology Litigation and Disputes
- U.S. Appellate and Supreme Court Litigation
-
Space and Satellite
-
Strategic Operations, Agreements and Regulation
- Commercial Law and Contracts
-
Sustainable Finance
-
Tax
-
Transfer Pricing
-
Transportation and Logistics
- Logistics
- Mobility
- Rail
- Shipping
- Uncrewed Aircraft Systems-Advanced Air Mobility-Drone Security
Manage my preferences
Languages
- Select all languages
- 中文
- Deutsch
- English
- Español
- Français
- 日本語
- Português
Manage my preferences
Countries
- Select all countries
-
Africa
- Central Africa
- Eastern Africa
- Northern Africa
- South Africa
- Southern Africa
- Western Africa
-
Asia Pacific
- Australia
- People's Republic of China
- Hong Kong
- Indonesia
- Japan
- Singapore
- South Korea
- Vietnam
-
Europe
- Belgium
- France
- Germany
- Hungary
- Ireland
- Italy
- Luxembourg
- Netherlands
- Poland
- Spain
- United Kingdom
-
Latin America
- Brazil
- Mexico
-
Middle East
- Saudi Arabia
- United Arab Emirates
-
North America
- United States
Before you go...
It looks like you have some unsaved changes to your preferences.
Would you like to keep or discard them?